Skip to main content
Equibles

ADAGE CAPITAL PARTNERS GP, L.L.C.

Position in IMUX — Immunic, Inc.

CIK 1165408 Boston, MA
Back to IMUX Full portfolio

Position in IMUX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,149,648
+$597,202 QoQ
Shares Held
139,860
0.0% QoQ
Ownership
1.03%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 55 holders
Holding Since
Jun 2022
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IMUX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ADAGE CAPITAL PARTNERS GP, L.L.C. holds $4,240,035,723 across 125 Biotechnology names. IMUX ranks #111 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ROIV
Roivant Sciences Ltd.
 10,349,328 $366,262,717
2 PRAX
Praxis Precision Medicines, Inc.
 1,015,480 $339,972,549
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 393,964 $195,693,737
4 TNGX
Tango Therapeutics, Inc.
 5,600,000 $175,056,000
5 BBIO
BridgeBio Pharma, Inc.
 2,252,000 $167,728,960
6 SYRE
Spyre Therapeutics, Inc.
 1,722,300 $152,905,794
7 TVTX
Travere Therapeutics, Inc.
 2,569,356 $145,965,114
8 RPRX
Royalty Pharma plc
 2,500,000 $140,175,000

All Filings in IMUX

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,149,648 139,860
2026-03-31 $1,552,446 1,398,600
2025-12-31 $746,852 1,398,600
2025-09-30 $1,233,565 1,398,600
2025-06-30 $976,222 1,398,600
2025-03-31 $1,524,474 1,398,600
2024-12-31 $1,398,600 1,398,600
2024-09-30 $9,230,769 5,594,406
2024-06-30 $6,209,790 5,594,406
2024-03-31 $7,384,615 5,594,406
2022-12-31 $433,678 309,770
2022-06-30 $2,085,123 600,900